מזומן למניה anebulo.com (ANEB)

סמל תאגידי ולוגו של Anebulo Pharma (ANEB)

Anebulo Pharmaceuticals brings together a team of scientists focused on rapid results in innovative biotech. Monitoring cash per share visualizes the company's liquid reserves, where the 0.22 indicator determines the metric's magnitude. Exclusive patents for ANEB-001 eliminate competition, which, combined with physician trust, builds a resilient venture reputation for the antidote developer.

anebulo.com (ANEB) - יתרות מזומנים למניה מ-04.07.2022 עד 07.03.2026

פילוחי מדדים מקיפים ואנליטיקה עבור anebulo.com (ANEB)

- ציטוטים ותחזית אנליסטים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:Anebulo Pharma - ANEB
סחורת הדגל של Anebulo Pharmaceuticals

To identify fundamental stability drivers, investors must evaluate a company's absolute liquidity. This metric is calculated by dividing total free cash flow by the number of shares outstanding. By analyzing cash per share, one can determine the capital cushion available to cover operating expenses. For Anebulo Pharmaceuticals (ANEB), this indicator is critical, as antidote development is independent of GDP cycles but requires a constant influx of external investment capital.